PI 3-Kinase p110 beta/PIK3CB Antibody (269020) [DyLight 680]
Novus Biologicals, part of Bio-Techne | Catalog # FAB2686Y
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
Western Blot
Label
DyLight 680 (Excitation = 692 nm, Emission = 712 nm)
Antibody Source
Monoclonal Mouse IgG2B Clone # 269020
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
E. coli-derived recombinant human PI 3-Kinase p110 beta
Met152-Val349
Accession # P42338
Met152-Val349
Accession # P42338
Specificity
Detects endogenous human PI 3-kinase p110 beta in Western blots.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG2B
Applications for PI 3-Kinase p110 beta/PIK3CB Antibody (269020) [DyLight 680]
Application
Recommended Usage
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A or G purified from hybridoma culture supernatant
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: PI 3-Kinase p110 beta
Long Name
Protein Tyrosine Phosphatase 1B
Alternate Names
PI 3Kinase p110 beta, PIK3CB
Gene Symbol
PIK3CB
Additional PI 3-Kinase p110 beta Products
Product Documents for PI 3-Kinase p110 beta/PIK3CB Antibody (269020) [DyLight 680]
Product Specific Notices for PI 3-Kinase p110 beta/PIK3CB Antibody (269020) [DyLight 680]
DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...